Mecamylamine overdosage: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{AK}} | {{CMG}}; {{AE}} {{AK}} | ||
== | ==Overdosage== | ||
Signs of overdosage include: [[hypotension ]](which may progress to peripheral vascular collapse), [[postural hypotension]], [[nausea]], [[vomiting]], [[diarrhea]], [[constipation]], [[paralytic ileus]], [[urinary retention]], [[dizziness]], [[anxiety]], dry mouth, [[mydriasis]], [[blurred vision]], or [[palpitations]]. A rise in [[intraocular pressure]] may occur. | Signs of overdosage include: [[hypotension ]](which may progress to peripheral vascular collapse), [[postural hypotension]], [[nausea]], [[vomiting]], [[diarrhea]], [[constipation]], [[paralytic ileus]], [[urinary retention]], [[dizziness]], [[anxiety]], dry mouth, [[mydriasis]], [[blurred vision]], or [[palpitations]]. A rise in [[intraocular pressure]] may occur. | ||
Revision as of 17:44, 12 March 2014
| Mecamylamine |
|---|
| Mecamylamine tablet®, Vecamyl® FDA Package Insert |
| Indications and Usage |
| Dosage and Administration |
| Contraindications |
| Warnings |
| Precautions |
| Adverse Reactions |
| Drug Interactions |
| Use in Specific Populations |
| Overdosage |
| Description |
| Clinical Pharmacology |
| Nonclinical Toxicology |
| How Supplied/Storage and Handling |
| Patient Counseling Information |
| Labels and Packages |
| Clinical Trials on Mecamylamine |
| ClinicalTrials.gov |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]
Overdosage
Signs of overdosage include: hypotension (which may progress to peripheral vascular collapse), postural hypotension, nausea, vomiting, diarrhea, constipation, paralytic ileus, urinary retention, dizziness, anxiety, dry mouth, mydriasis, blurred vision, or palpitations. A rise in intraocular pressure may occur.
Pressor amines may be used to counteract excessive hypotension. Since patients being treated with ganglion blockers are more than normally reactive to pressor amines, small doses of the latter are recommended to avoid excessive response.
The oral LD50 of Mecamylamine HCl in the mouse is 92 mg/kg.[1]
References
- ↑ "VECAMYL (MECAMYLAMINE HYDROCHLORIDE) TABLET [MANCHESTER PHARMACEUTICALS]". Retrieved 10 March 2014.